|
| 35976058 | Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. | Neuro Oncol | 2023 |
| 35976058 | Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. | Neuro Oncol | 2023 |
| 36227281 | Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. | Neuro Oncol | 2023 |
| 37646878 | Outcomes following surgical resection of trigeminal schwannomas: a systematic review and meta-analysis. | Neurosurg Rev | 2023 |
| 37711972 | Radiotherapy and radiosurgery for meningiomas. | Neurooncol Adv | 2023 |
| 37702515 | In Reply: International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends. | Neurosurgery | 2023 |
| 37418417 | International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach. | Neurosurgery | 2023 |
| 36701694 | Pituitary Stalk Stretch Predicts Postoperative Diabetes Insipidus After Pituitary Macroadenoma Transsphenoidal Resection. | Oper Neurosurg (Hagerstown) | 2023 |
| 37389475 | International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends. | Neurosurgery | 2023 |
| 37444483 | Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. | Cancers (Basel) | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 36993679 | Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. | Res Sq | 2023 |
| 36729132 | Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. | Acta Neuropathol | 2023 |
| 37164210 | Validating the VS-5 Score for Predicting Outcomes After Vestibular Schwannoma Resection in an Institutional Cohort. | World Neurosurg | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 37711972 | Radiotherapy and radiosurgery for meningiomas. | Neurooncol Adv | 2023 |
| 37702515 | In Reply: International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends. | Neurosurgery | 2023 |
| 37646878 | Outcomes following surgical resection of trigeminal schwannomas: a systematic review and meta-analysis. | Neurosurg Rev | 2023 |
| 37503127 | NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. | bioRxiv | 2023 |
| 37292686 | Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. | Res Sq | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 36993679 | Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. | Res Sq | 2023 |
| 37389475 | International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends. | Neurosurgery | 2023 |
| 37418417 | International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach. | Neurosurgery | 2023 |
| 37444483 | Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. | Cancers (Basel) | 2023 |
| 37164210 | Validating the VS-5 Score for Predicting Outcomes After Vestibular Schwannoma Resection in an Institutional Cohort. | World Neurosurg | 2023 |
| 36729132 | Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. | Acta Neuropathol | 2023 |
| 36701694 | Pituitary Stalk Stretch Predicts Postoperative Diabetes Insipidus After Pituitary Macroadenoma Transsphenoidal Resection. | Oper Neurosurg (Hagerstown) | 2023 |
| 36227281 | Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. | Neuro Oncol | 2023 |
| 34192974 | Tessier 30 Facial Clefts-A Literature Review of 72 Cases (1996-2020), Suggested Treatment Protocol, Outcome Measures, Minimum Dataset for Future Case Reports, and Registries. | Cleft Palate Craniofac J | 2022 |
| 36303473 | Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma. | J Neurosurg | 2022 |
| 35759011 | Intratumor and informatic heterogeneity influence meningioma molecular classification. | Acta Neuropathol | 2022 |
| 35384923 | Machine Learning-Based Analysis and Prediction of Unplanned 30-Day Readmissions After Pituitary Adenoma Resection: A Multi-Institutional Retrospective Study With External Validation. | Neurosurgery | 2022 |
| 36285000 | Endoscopic endonasal transclival petroclival meningioma resection. | Neurosurg Focus Video | 2022 |
| 35870782 | Outcomes Following Penetrating Brain Injuries in Military Settings: A Systematic Review and Meta-Analysis. | World Neurosurg | 2022 |
| 36321282 | Outcomes following stereotactic radiosurgery for foramen magnum meningiomas: a single-center experience and systematic review of the literature. | Neurosurg Focus | 2022 |
| 36315366 | Radiotherapy for meningiomas. | J Neurooncol | 2022 |
| 35534562 | Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. | Nat Genet | 2022 |
| 36497370 | Clinical Management of Supratentorial Non-Skull Base Meningiomas. | Cancers (Basel) | 2022 |
| 34192974 | Tessier 30 Facial Clefts-A Literature Review of 72 Cases (1996-2020), Suggested Treatment Protocol, Outcome Measures, Minimum Dataset for Future Case Reports, and Registries. | Cleft Palate Craniofac J | 2022 |
| 35061986 | Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. | J Neurosurg | 2022 |
| 34508644 | A molecularly integrated grade for meningioma. | Neuro Oncol | 2022 |
| 35384923 | Machine Learning-Based Analysis and Prediction of Unplanned 30-Day Readmissions After Pituitary Adenoma Resection: A Multi-Institutional Retrospective Study With External Validation. | Neurosurgery | 2022 |
| 35534562 | Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. | Nat Genet | 2022 |
| 35759011 | Intratumor and informatic heterogeneity influence meningioma molecular classification. | Acta Neuropathol | 2022 |
| 36497370 | Clinical Management of Supratentorial Non-Skull Base Meningiomas. | Cancers (Basel) | 2022 |
| 36315366 | Radiotherapy for meningiomas. | J Neurooncol | 2022 |
| 35870782 | Outcomes Following Penetrating Brain Injuries in Military Settings: A Systematic Review and Meta-Analysis. | World Neurosurg | 2022 |
| 36303473 | Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma. | J Neurosurg | 2022 |